STAT News

MARCH 27, 2023

Novartis announced data Monday that could set up one of the biggest marketing battles in cancer. Continue to STAT+ to read the full story… At issue is the market for medicines called CDK 4/6 inhibitors. The first of these drugs, Pfizer’s Ibrance, is a $5-billion-a-year product and one of that company’s top sellers.

Drugs 98

Drugs Marketing Medicine Production 98

STAT News

DECEMBER 12, 2022

Roche announced Monday that Bill Anderson, CEO of its pharmaceuticals division, will step down after nearly four years at the helm.   Continue to STAT+ to read the full story…   Continue to STAT+ to read the full story… His last day will be Dec.

98

98

STAT News

NOVEMBER 10, 2022

Sage announced this week that Jonas would leave the company to join a private equity firm. Continue to STAT+ to read the full story… He has been part of the C-suite at Sage Therapeutics since 2013. He helped the company go public, build a pipeline of new antidepressants and other psychiatric medications, and sign a $1.5

119

119

STAT News

FEBRUARY 22, 2023

The Cambridge biotech company announced Wednesday that it will partner with Life Edit Therapeutics to develop potentially permanent treatments for rare genetic diseases and other conditions. Continue to STAT+ to read the full story…

Gene Editing 126

Gene Editing Gene Genetic Disease Gene Therapy 126

STAT News

NOVEMBER 18, 2022

Biosplice’s bid to transform the treatment of everything from arthritis to cancer ran into a snag this week, with the San Diego biotech announcing that its experimental osteoarthritis drug failed to benefit patients in a pair of Phase 3 clinical trials. Continue to STAT+ to read the full story…

Trials 128

Trials Clinical Trials Clinical Trials Drugs 128

STAT News

NOVEMBER 28, 2022

A drug developed by Axsome Therapeutics significantly reduced a common side effect of Alzheimer’s disease — agitation — the company announced Monday. Continue to STAT+ to read the full story… The therapy, AXS-05, met its primary goal of delaying time to relapse and preventing patients from relapsing.

Drugs 98

Drugs Development 98

STAT News

APRIL 4, 2023

But in a tweet yesterday, the upstart announced that it is selling the Invokana and Invokamet diabetes drugs from Janssen, a unit at Johnson & Johnson. Continue to STAT+ to read the full story… The average retail price is $676.14.

Branding 140

Branding Medicine Manufacturing Drugs 140

STAT News

JANUARY 5, 2023

Biogen announced Thursday that it will be splitting the head of R&D role into two, with Priya Singhal being named as the new head of development. Continue to STAT+ to read the full story… The company has initiated a search for a new research chief, it said in a press release.

Development 114

Development Research 114

STAT News

MARCH 16, 2023

The announcement Thursday comes just weeks after the company said the FDA had told it an advisory panel meeting to review the treatment, called SRP-9001, would not be necessary. Continue to STAT+ to read the full story…

Gene Therapy 105

Gene Therapy Gene Drugs 105

Rethinking Clinical Trials

FEBRUARY 27, 2024

Participants will learn how to write compelling specific aims, how to tell a story, and create a conceptual model. The post February 27, 2024: HCSRN Announces Preconference Grant Writing Workshop, Extends Early-Bird Registration appeared first on Rethinking Clinical Trials. Early-bird registration is open until February 18.

Clinical Trials 130

Clinical Trials Clinical Trials Medicine Research 130

STAT News

OCTOBER 10, 2022

Florida-based American Oncology Network, a company with more than 100 affiliated doctors across 18 states, announced last week it plans to go public.   Continue to STAT+ to read the full story… The news comes about a year after another large oncology provider chain hit the stock market.

Doctors 105

Doctors Doctor Marketing 105

STAT News

JANUARY 17, 2023

The move expands an effort announced last May  to provide about two dozen patent-protected products to 27 low-income countries and another 18 lower-middle-income countries, most of which are located in Africa. Continue to STAT+ to read the full story…

Medicine 111

Medicine Vaccination Vaccine Production 111

STAT News

MARCH 28, 2023

Intra-Cellular Therapies, maker of an approved treatment for schizophrenia and bipolar depression, announced positive results from a new clinical trial on Tuesday that could potentially expand use of its drug to other types of mood disorders. Continue to STAT+ to read the full story…

Clinical Trials 98

Clinical Trials Clinical Trials Sales Trials 98

STAT News

JANUARY 16, 2023

The company, which offers genetic tests for people who are pregnant or planning to have a child as well as for conditions such as heart disease and hereditary cancers, announced last July that it would lay off more than 1,000 employees , more than a third of its workforce at the time. Continue to STAT+ to read the full story…

Genetics 98

Genetics Genome Genomics 98

STAT News

JANUARY 11, 2023

But genomics startup Element Biosciences on Wednesday announced it can now read a whole human genome for as little as $200 — the cost of a couple trips to the grocery store. Element’s announcement, made during the J.P. Continue to STAT+ to read the full story…

Genome 98

Genome Genomics DNA Genetics 98

STAT News

JANUARY 11, 2023

Verily, a health technology company spun out of tech giant Alphabet, announced Wednesday that it is restructuring its management team and business and cutting 15% of its workforce. Continue to STAT+ to read the full story…

Clinical Trials 98

Clinical Trials Clinical Trials Production Trials 98

STAT News

FEBRUARY 8, 2023

True to form, Ackman announced last week that he and an anonymous donor had pledged $25 million over five years toward a new research lab for David Sabatini, a former star scientist from MIT and Whitehead Institute, whose career imploded in 2021 amid allegations of workplace misconduct and sexual harassment.

Scientist 98

Scientist Research 98

STAT News

SEPTEMBER 8, 2022

The two companies announced a multifaceted, 10-year partnership Wednesday that will kick off in January with a co-branded Medicare Advantage plan in Georgia. Continue to STAT+ to read the full story…

Branding 111

Branding Marketing 111

STAT News

DECEMBER 12, 2022

The deal is the largest pharma merger announced this year, and it represents the most that Amgen has spent on an acquisition since its $16 billion purchase of Immunex in 2001. Continue to STAT+ to read the full story…

Marketing 105

Marketing Drugs 105

Drug Discovery World

MARCH 18, 2024

DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. The latest episode of the DDW Highlights podcast is now available to listen to below.

Drugs 52

Drugs 52

Drug Discovery World

MARCH 18, 2024

DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. The latest episode of the DDW Highlights podcast is now available to listen to below.

Drugs 52

Drugs 52

STAT News

NOVEMBER 3, 2022

The FDA was set to announce an approval decision for the Apellis drug on Nov. Continue to STAT+ to read the full story… The review will now be extended by three months to February 2023.

FDA Approval 98

FDA Approval Drugs 98

STAT News

NOVEMBER 10, 2022

Viehbacher, 62, will take the reins Monday, succeeding CEO Michel Vounatsos, who announced his impending resignation in May. Continue to STAT+ to read the full story…

Drugs 97

Drugs 97

STAT News

SEPTEMBER 8, 2022

WASHINGTON – On Tuesday, a group of more than 30 attorneys general announced they had reached a “landmark” $438.5 Continue to STAT+ to read the full story… million settlement with the e-cigarette maker Juul over its alleged marketing toward children.

Marketing 105

Marketing Production 105

STAT News

JULY 22, 2022

  By the time the tech giant made the bombshell announcement that it was buying One Medical on Thursday, it had already aggressively scaled what began as a modest primary care pilot for its Seattle-area employees.   Continue to STAT+ to read the full story…

111

111

STAT News

DECEMBER 15, 2022

Bay Area biotech Guardant Health on Thursday announced results from a massive trial of its blood-based test for the early detection of colon cancer that, while good enough for Medicare reimbursement, underwhelmed observers. Continue to STAT+ to read the full story…

Trials 98

Trials Marketing 98

STAT News

MARCH 14, 2023

After months of vigorous deliberations, I’m thrilled to announce our 2023 STATUS List — the definitive roster of leaders in health, medicine, and the life sciences whose work over the past year has advanced those fields. All have compelling stories to tell. There were, of course, many contenders to choose from.

Life Science 98

Life Science DNA Medicine 98

STAT News

MARCH 13, 2023

The granddaddy of activist investors announced Monday morning that he’s taken a stake in Illumina and wants three handpicked directors added to the company’s board. Continue to STAT+ to read the full story… Illumina, the DNA sequencing giant whose stock has fallen 40% in two years, already had problems.

DNA 98

DNA Genetics 98

STAT News

MARCH 9, 2023

WASHINGTON — An unusual new alliance of the brand-drug lobby PhRMA and community health centers is forming to push reforms in the 340B drug discount program, the groups announced Thursday. Continue to STAT+ to read the full story…

Branding 98

Branding Drugs 98

STAT News

AUGUST 15, 2022

On Monday, Brainstorm announced its intention to seek approval from the FDA for its ALS treatment, called NurOwn, regardless of the agency’s past opposition. Continue to STAT+ to read the full story…

FDA Approval 98

FDA Approval Clinical Trials Clinical Trials Trials 98

STAT News

FEBRUARY 13, 2023

Sanofi’s head of research and development, John Reed, is leaving the pharmaceutical giant to pursue a new opportunity, the company announced Monday. Continue to STAT+ to read the full story… Reed joined Sanofi in 2018, after holding a similar position at Swiss pharma company Roche.

Life Science 98

Life Science Pharma Companies Medicine Research 98

STAT News

OCTOBER 16, 2022

The EPPO did not, however, specify what it is investigating in its brief announcement about its probe into Covid-19 contracts. ” Continue to STAT+ to read the full story… “This exceptional confirmation comes after the extremely high public interest,” the EPPO stated.

Vaccination 144

Vaccination Vaccine 144

STAT News

NOVEMBER 15, 2022

Amazon has been making significant shifts in its health care strategy in the last few months: In July, it announced plans to acquire primary care company One Medical in a deal valued at $3.9 Continue to STAT+ to read the full story… In August, it was in a bidding war for home health care company Signify Health.

119

119

STAT News

JANUARY 5, 2023

The setback, announced Thursday, will cut the company’s size to 220 workers by the end of the first quarter of this year. Continue to STAT+ to read the full story… According to Pitchbook, Fate had 545 employees in 2022, up from 449 recorded in the company’s 2021 annual report.

Drugs 134

Drugs Development 134

STAT News

JANUARY 24, 2023

In November, the company announced the launch of Amazon Clinic, a telehealth service that lets patients message with a third-party provider to get prescriptions for common conditions. Continue to STAT+ to read the full story… Those prescriptions, like the medications offered on RxPass, can be filled through Amazon Pharmacy.

Pharmacy 98

Pharmacy 98

STAT News

JANUARY 9, 2023

In setting such a price, Moderna will pursue the same path as Pfizer, which last year also announced plans to charge $110 to $130 a dose this year for its own Covid-19 shot. Continue to STAT+ to read the full story… The Moderna pricing was first reported by The Wall Street Journal and confirmed by a company spokesperson.

Vaccination 111

Vaccination Vaccine Pharmacy Drugs 111

STAT News

JANUARY 9, 2023

Morgan Healthcare Conference , four life science companies had already announced acquisitions worth roughly $4.5 Continue to STAT+ to read the full story… SAN FRANCISCO — Within the first hours of the J.P. billion in total, raising hopes that this could be a more active year for pharma mergers and acquisitions.

Life Science 98

Life Science 98